|
Markt geschlossen -
Andere Börsenplätze
|
% 5 Tage | Veränd. 1. Jan. | ||
| 158.90 CHF | -3.05% |
|
-4.05% | -1.97% |
| 13.01. | GALDERMA GROUP AG : Deutsche Bank Research gibt neutrale Einschätzung | ZM |
| 13.01. | Aktien Schweiz: Schwächer - Anleger vorsichtig vor US-Daten und Ergebnissen | AW |
Hauptkonkurrenten
| Umsatz (Y-1) | Nettogewinn (Y-1) | EBIT-Marge (Y-1) | ROE (Y-1) | ROA (Y-1) | Verschuldungsgrad (Y-1) | ||
|---|---|---|---|---|---|---|---|
| 4.41 Mrd. | 5.24% | 16.73% | 3.51% | 1.84% | 2.29x | ||
| 45.02 Mrd. | 14.74% | 19.98% | 20.6% | 11.85% | 0.42x | ||
| 10.36 Mrd. | 6.62% | 9.01% | 10.5% | 8.3% | -0.96x | ||
| 6.3 Mrd. | -1.09% | 0.76% | -1.73% | -0.84% | 3.18x | ||
| 1.31 Mrd. | 8.53% | 18.64% | 15.97% | 9.43% | 0.36x | ||
| 2.63 Mrd. | 15.27% | 5.68% | 11.8% | 9.36% | -0.4x | ||
| 1.48 Mrd. | 14.4% | 17.38% | 32.53% | 19.73% | -2.04x | ||
| 931 Mio. | 11.5% | 10.89% | 37.2% | 23.23% | -0.38x | ||
| 1.45 Mrd. | 11.32% | 18.92% | 22.76% | 11.82% | - | ||
| 5.89 Mrd. | -6.47% | 14.47% | 5.12% | 1.57% | 3.42x | ||
| 786 Mio. | 8.77% | 10.89% | 8.53% | 6.36% | -1.36x | ||
| 912 Mio. | 14.75% | 20.22% | 19.41% | 12.98% | -0.29x | ||
| 647 Mio. | 15.69% | 21.73% | 35.9% | 28.76% | -0.67x | ||
| 407 Mio. | 11.5% | 12.83% | 10.08% | 7.18% | -3.28x | ||
| 2.05 Mrd. | 2.32% | 5.36% | 2.8% | 5.74% | -3.81x | ||
| 276 Mio. | 32.78% | 45.07% | 10.72% | 11.04% | - | ||
| 2.88 Mrd. | 5.92% | 5.85% | 9.66% | 3.12% | -0.65x | ||
| 581 Mio. | 2.59% | 2.95% | 5.26% | 5.27% | - | ||
| 1.47 Mrd. | 4.08% | 8.1% | 20.39% | 4.92% | 2.39x | ||
| Durchschnitt | 4.73 Mrd. | 9.39% | 13.97% | 14.79% | 9.56% | -0.11x | |
| Gewichteter Durchschnitt nach Marktkapitalisierung | 32.16 Mrd. | 12.3% | 18.05% | 17.09% | 10.06% | 0.57x |
- Börse
- Aktien
- A407X6 Aktie
- Sektor Galderma Group AG
- Finanzielle Vergleiche
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen
MarketScreener is also available in this country: United States.
Switch edition
Bei der aktuellen länderspezifischen Edition bleiben
















